CNSP
CNS Pharmaceuticals, Inc.
-0.16 (-2.91%)5.34USD1.0K成交股數7.8M市值–本益比(近四季)226.8股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | 7K | 7K | 13K | 8K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.2M | 3.5M | 3.2M | 2.2M | 1.2M | 3.2M | 4.2M | 1.1M | 2.4M | 4.3M | 3.4M | 2.8M |
| 銷售管理費用 | 1.5M | 1.4M | 2.8M | 1.1M | 1.2M | 1.1M | 1.4M | 1.4M | 1.1M | 1.1M | 1.1M | 1.2M |
| 營業利益 | −2.7M+12% | −5.0M+15% | −6.0M+6% | −3.3M+29% | −2.4M-32% | −4.3M-19% | −5.6M+24% | −2.5M-37% | −3.5M | −5.4M | −4.5M | −4.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | -52,664.6% | -76,826.2% | -35,192.4% | -51,594.3% |
| 稅後淨利 | −2.6M+9% | −4.9M+15% | 9.9M-276% | −3.2M+27% | −2.4M-33% | −4.3M-132% | −5.6M+24% | −2.5M-37% | −3.5M | 13.5M | −4.5M | −4.0M |
| 淨利率 | – | – | – | – | – | – | – | – | -52,663.0% | 192,189.7% | -35,106.7% | -51,541.1% |
| 稀釋 EPS | -0.38-94% | -7.30-61% | -4.64-97% | -5.76-100% | -6.42-99% | -18.93-100% | -153.20+183% | -4049.20+7708% | -1020.48 | -12400.52 | -54.14 | -51.86 |
| 稀釋股數 | 6.8M | 676K | 443K | 559K | 370K | 227K | 36.6K | 625 | 3.5K | 1.5K | 83.5K | 77.5K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 20.0M | 3.0M | 7.2M | 9.9M | 12.1M | 13.0M | 7.0M | 1.5M | 815K | 549K | 910K | 4.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 21.9M | 4.7M | 8.6M | 11.9M | 14.5M | 13.7M | 7.4M | 2.5M | 1.7M | 1.7M | 2.3M | 6.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 3.7M | 4.6M | 4.1M | 2.0M | 1.4M | 2.8M | 4.1M | 6.8M | 6.1M | 6.1M | 4.1M | 4.0M |
| 股東權益 | 18.2M | 71K | 4.5M | 9.9M | 13.1M | 11.0M | 3.4M | −4.3M | −4.4M | −4.4M | −1.7M | 2.5M |
| 負債比 | 17.0% | 98.5% | 47.5% | 16.5% | 9.5% | 20.2% | 54.8% | 273.9% | 366.8% | 360.6% | 174.8% | 62.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.6M+43% | – | – | – | −3.2M | – | – | −3.2M | – | – | – |
| 資本支出 | – | 6K | – | – | – | 0.00 | – | – | – | – | – | – |
| 自由現金流 | – | −4.7M+44% | – | – | – | −3.2M | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −16K | –% | -35.75 | −13.8M |
| FY2024 | – | – | −15K | –% | -466.89 | −17.1M |
| FY2023 | 28K | – | −19K | -68.1% | -12509.11 | −14.1M |
| FY2022 | 0.00 | – | −15.3M | –% | -11.22 | −10.6M |
| FY2021 | – | – | −14.5M | –% | -16.50 | −13.5M |
| FY2020 | – | – | −9.5M | –% | -0.57 | −7.3M |
| FY2019 | – | – | −3.9M | –% | -0.28 | −3.6M |
| FY2018 | – | – | −7.4M | –% | -0.70 | −716K |